81 related articles for article (PubMed ID: 1746204)
1. Simultaneous dosage of oestrone-3-glycuronide and pregnanediol-3-glycuronide in urines to monitor the fertile period in the woman.
Cortesi S; Fortunato A; Marzot E; Soffiati G
Acta Eur Fertil; 1991; 22(1):27-31. PubMed ID: 1746204
[No Abstract] [Full Text] [Related]
2. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between indicators of the fertile period of the menstrual cycle and ultrasonically-determined ovulation].
Croce P; Quarenghi A; Montanari G; Barbato M; Pravettoni G; Bertolotti G
Minerva Endocrinol; 1989; 14(3):147-52. PubMed ID: 2622425
[TBL] [Abstract][Full Text] [Related]
4. Recycling ovulation markers.
Lewis JG; Elder PA
N Z Med J; 1993 Apr; 106(954):165-6. PubMed ID: 8386820
[No Abstract] [Full Text] [Related]
5. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
[TBL] [Abstract][Full Text] [Related]
6. Prediction of ovulation with the assessment of LH and the E1G/P2G ratio in urinary samples.
Baviera G; Carroccio G; Scurria L; Pizzi V; Scarselli G
Acta Eur Fertil; 1988; 19(3):139-42. PubMed ID: 3067480
[TBL] [Abstract][Full Text] [Related]
7. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
[TBL] [Abstract][Full Text] [Related]
8. Predicting menstrual migraine with a home-use fertility monitor.
MacGregor EA; Frith A; Ellis J; Aspinall L
Neurology; 2005 Feb; 64(3):561-3. PubMed ID: 15699399
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of using paper impregnated with urine instead of liquid urine for assessing ovarian activity.
Wasalathanthri S; Tennekoon KH; Sufi S
Ceylon Med J; 2003 Mar; 48(1):4-6. PubMed ID: 12795010
[TBL] [Abstract][Full Text] [Related]
10. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
Adekunle AO; Collins WP; Whitehead MI
Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and specificity of ultrasound indices of ovulation in spontaneous cycles.
Ecochard R; Marret H; Rabilloud M; Bradaï R; Boehringer H; Girotto S; Barbato M
Eur J Obstet Gynecol Reprod Biol; 2000 Jul; 91(1):59-64. PubMed ID: 10817880
[TBL] [Abstract][Full Text] [Related]
12. Using an ovarian monitor as an adjunct to natural family planning.
Cavero C
J Nurse Midwifery; 1995; 40(3):269-76. PubMed ID: 7798132
[TBL] [Abstract][Full Text] [Related]
13. Variability in the hormonally estimated fertile phase of the menstrual cycle.
Fehring RJ; Schneider M
Fertil Steril; 2008 Oct; 90(4):1232-5. PubMed ID: 18249381
[TBL] [Abstract][Full Text] [Related]
14. Chemical and homogeneous enzyme immunoassay methods for the measurement of estrogens and pregnanediol and their glucuronides in urine.
Brown JB; Blackwell LF; Cox RI; Holmes JM; Smith MA
Prog Clin Biol Res; 1988; 285():119-38. PubMed ID: 3068673
[No Abstract] [Full Text] [Related]
15. Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.
Merlo AB; Farinati Z; Quiroga S; Nagle CA; Carril LM; Lahoz M; Mendizabal AF
Int J Fertil; 1984; 29(3):189-93. PubMed ID: 6152260
[TBL] [Abstract][Full Text] [Related]
16. Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites.
Baird DD; McConnaughey DR; Weinberg CR; Musey PI; Collins DC; Kesner JS; Knecht EA; Wilcox AJ
Epidemiology; 1995 Sep; 6(5):547-50. PubMed ID: 8562634
[TBL] [Abstract][Full Text] [Related]
17. The OVEIA Dual Analyte assay--a new method for profiling the menstrual cycle.
Baker TS
Prog Clin Biol Res; 1988; 285():101-18. PubMed ID: 3231642
[TBL] [Abstract][Full Text] [Related]
18. An assessment of the dual-analyte enzyme immunoassay for ovulation timing.
Lenton EA; King H; Johnson J; Amos S
Hum Reprod; 1989 May; 4(4):378-80. PubMed ID: 2663906
[TBL] [Abstract][Full Text] [Related]
19. Personal hormone monitoring for contraception.
Bonnar J; Flynn A; Freundl G; Kirkman R; Royston R; Snowden R
Br J Fam Plann; 1999 Jan; 24(4):128-34. PubMed ID: 10023097
[TBL] [Abstract][Full Text] [Related]
20. The OVEIA assay, a simultaneous measurement of oestrone and pregnanediol glucuronides, for studying the treatment of infertility patients.
Anthony F; Aldrich C; Sharp NC; Smith EM; Masson GM; Dennis KJ
Hum Reprod; 1988 Oct; 3(7):870-2. PubMed ID: 3182977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
